Latest News
Stay up to date with the latest press coverage of BrainCool in the community and in the industry.
BrainCool AB (publ) Receives US FDA De Novo Clearance for the Cooral® System for Reduction of Oral Mucositis
Annapolis, Maryland —November 1st, 2022—BrainCool Inc a subsidiary of the Swedish medical device innovator BrainCool AB (publ), announced the launch of Cooral® System which has been approved though a De Novo clearance by the U.S. [...]
BrainCool TTM Aware Summit 2021
Compelling lessons and insight concerning Targeted Temperature Management. Key Opinion Leaders will share; How, Why and When to employ TTM.
Q&A: The importance of ‘high-quality targeted temperature management’ in post-arrest care
A new algorithm that includes targeted temperature management in post-cardiac arrest care was included in the 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.